Adalta Ltd has released a press release.
Entitlement Offer Results and Shortfall Notification
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from AdAlta
- Completion of Capital Raise - $5 million
- AD-214 manufacturing update
- Manufacturing update
- Appendix 4C - Quarter ended 30 September 2018
- Change of Registry Address: Automic P/L - Sydney Office
Later from AdAlta
- GLP toxicology study commences
- Executive team changes
- AdAlta secures licensing deal with GE Healthcare
- Receipt of R&D Tax Incentive
- Tim Oldham Appointed as Chief Executive Officer
Follow AdAlta into a list and get an email when it puts out news.
Follow AdAlta